标题
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 208, Issue 10, Pages 1949-1962
出版商
Rockefeller University Press
发表日期
2011-09-20
DOI
10.1084/jem.20101956
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Modulation of human T-cell functions by reactive nitrogen species
- (2011) Tihana Kasic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- In vivo tissue engineering of functional skeletal muscle by freshly isolated satellite cells embedded in a photopolymerizable hydrogel
- (2011) Carlo Alberto Rossi et al. FASEB JOURNAL
- Macrophage Expression of Hypoxia-Inducible Factor-1 Suppresses T-Cell Function and Promotes Tumor Progression
- (2010) A. L. Doedens et al. CANCER RESEARCH
- SnapShot: Reactive Oxygen Intermediates (ROI)
- (2010) Carl Nathan et al. CELL
- Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
- (2010) Ilaria Marigo et al. IMMUNITY
- Control of immune response by amino acid metabolism
- (2010) Ursula Grohmann et al. IMMUNOLOGICAL REVIEWS
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
- (2010) Cesar A. Corzo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes
- (2009) S. Ugel et al. BLOOD
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- CCL2 Blockade Augments Cancer Immunotherapy
- (2009) Z. G. Fridlender et al. CANCER RESEARCH
- Tumor Cell-Microenvironment Interaction Models Coupled with Clinical Validation Reveal CCL2 and SNCG as Two Predictors of Colorectal Cancer Hepatic Metastasis
- (2009) H. Hu et al. CLINICAL CANCER RESEARCH
- Adoptive cell therapy for the treatment of patients with metastatic melanoma
- (2009) Steven A Rosenberg et al. CURRENT OPINION IN IMMUNOLOGY
- Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner
- (2009) L. Izhak et al. JOURNAL OF IMMUNOLOGY
- Protein Tyrosine Nitration: Selectivity, Physicochemical and Biological Consequences, Denitration, and Proteomics Methods for the Identification of Tyrosine-Nitrated Proteins
- (2009) Nicolas Abello et al. JOURNAL OF PROTEOME RESEARCH
- Immunological applications of single-domain llama recombinant antibodies isolated from a naïve library
- (2009) Ana Monegal et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Monocyte-Mediated Defense Against Microbial Pathogens
- (2008) Natalya V. Serbina et al. Annual Review of Immunology
- Equilibrium between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma
- (2008) B. Zhang et al. CANCER RESEARCH
- Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer
- (2008) C. Mennuni et al. CANCER RESEARCH
- Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice
- (2008) Béatrice Breart et al. JOURNAL OF CLINICAL INVESTIGATION
- Vascular normalization in Rgs5-deficient tumours promotes immune destruction
- (2008) Juliana Hamzah et al. NATURE
- Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation
- (2007) Antonella Viola et al. Annual Review of Pharmacology and Toxicology
- Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
- (2007) Ronald J Buckanovich et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started